Trial Outcomes & Findings for Continuous Chest Compressions vs AHA Standard CPR of 30:2 (NCT NCT01372748)

NCT ID: NCT01372748

Last Updated: 2016-12-28

Results Overview

Patients may die in the field (outside of the hospital at the time of the cardiac arrest), at the emergency room, in the hospital, or they are discharged alive from the hospital.

Recruitment status

COMPLETED

Study phase

PHASE4

Target enrollment

23711 participants

Primary outcome timeframe

Patients will be followed from the time of the cardiac arrest until death or hospital discharge, whichever occurs first.

Results posted on

2016-12-28

Participant Flow

In this cluster randomized crossover trial, there are situations where age and gender are not known prior to the treatment being administered. These missing data account for the discrepancy between the enrollment number in the protocol section (23,711) and those in the participant flow module (23,687).

Participant milestones

Participant milestones
Measure
Standard CPR
American Heart Association (AHA)recommended cardiopulmonary resuscitation (CPR) of 30 compressions with brief pause for 2 ventilations Standard CPR: 30:2 CPR consists of 3 cycles of standard CPR with each cycle consisting of 30 chest compressions with a pause for 2 ventilations at a compression:ventilation ratio of 30:2. CCC consists of a series of three cycles of continuous chest compressions without pauses for ventilation. In either group, each cycle will be followed by rhythm analysis until three cycles are completed or restoration of spontaneous circulation (ROSC), whichever occurs first.
Continuous Chest Compressions
Continuous compression CPR Continuous chest compressions: Continuous chest compressions during the first 6 minutes of the resuscitation.
Overall Study
STARTED
11045
12642
Overall Study
COMPLETED
11022
12603
Overall Study
NOT COMPLETED
23
39

Reasons for withdrawal

Reasons for withdrawal
Measure
Standard CPR
American Heart Association (AHA)recommended cardiopulmonary resuscitation (CPR) of 30 compressions with brief pause for 2 ventilations Standard CPR: 30:2 CPR consists of 3 cycles of standard CPR with each cycle consisting of 30 chest compressions with a pause for 2 ventilations at a compression:ventilation ratio of 30:2. CCC consists of a series of three cycles of continuous chest compressions without pauses for ventilation. In either group, each cycle will be followed by rhythm analysis until three cycles are completed or restoration of spontaneous circulation (ROSC), whichever occurs first.
Continuous Chest Compressions
Continuous compression CPR Continuous chest compressions: Continuous chest compressions during the first 6 minutes of the resuscitation.
Overall Study
Lost to Follow-up
16
34
Overall Study
Withdrawal by Subject
7
5

Baseline Characteristics

Continuous Chest Compressions vs AHA Standard CPR of 30:2

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Standard CPR
n=11045 Participants
American Heart Association (AHA)recommended cardiopulmonary resuscitation (CPR) of 30 compressions with brief pause for 2 ventilations Standard CPR: 30:2 CPR consists of 3 cycles of standard CPR with each cycle consisting of 30 chest compressions with a pause for 2 ventilations at a compression:ventilation ratio of 30:2. CCC consists of a series of three cycles of continuous chest compressions without pauses for ventilation. In either group, each cycle will be followed by rhythm analysis until three cycles are completed or restoration of spontaneous circulation (ROSC), whichever occurs first.
Continuous Chest Compressions
n=12642 Participants
Continuous compression CPR Continuous chest compressions: Continuous chest compressions during the first 6 minutes of the resuscitation.
Total
n=23687 Participants
Total of all reporting groups
Age, Continuous
66.2 years
STANDARD_DEVIATION 17.0 • n=5 Participants
66.4 years
STANDARD_DEVIATION 17.2 • n=7 Participants
66.3 years
STANDARD_DEVIATION 17.1 • n=5 Participants
Gender
Female
3926 Participants
n=5 Participants
4618 Participants
n=7 Participants
8544 Participants
n=5 Participants
Gender
Male
7119 Participants
n=5 Participants
8024 Participants
n=7 Participants
15143 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
14 Participants
n=5 Participants
12 Participants
n=7 Participants
26 Participants
n=5 Participants
Race (NIH/OMB)
Asian
123 Participants
n=5 Participants
140 Participants
n=7 Participants
263 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
23 Participants
n=5 Participants
28 Participants
n=7 Participants
51 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
1246 Participants
n=5 Participants
1350 Participants
n=7 Participants
2596 Participants
n=5 Participants
Race (NIH/OMB)
White
1795 Participants
n=5 Participants
1931 Participants
n=7 Participants
3726 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
3 Participants
n=5 Participants
1 Participants
n=7 Participants
4 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
7841 Participants
n=5 Participants
9180 Participants
n=7 Participants
17021 Participants
n=5 Participants
Region of Enrollment
Canada
6711 participants
n=5 Participants
8010 participants
n=7 Participants
14721 participants
n=5 Participants
Region of Enrollment
United States
4334 participants
n=5 Participants
4632 participants
n=7 Participants
8966 participants
n=5 Participants

PRIMARY outcome

Timeframe: Patients will be followed from the time of the cardiac arrest until death or hospital discharge, whichever occurs first.

Population: The primary aim of the trial is to compare survival to hospital discharge after continuous chest compressions (CCC) versus standard American Heart Association (AHA) recommended cardiopulmonary resuscitation (CPR) with interrupted chest compressions (ICC) in patients with out-of-hospital cardiac arrest (OOHCA).

Patients may die in the field (outside of the hospital at the time of the cardiac arrest), at the emergency room, in the hospital, or they are discharged alive from the hospital.

Outcome measures

Outcome measures
Measure
Standard CPR
n=11022 Participants
American Heart Association (AHA)recommended cardiopulmonary resuscitation (CPR) of 30 compressions with brief pause for 2 ventilations Standard CPR: 30:2 CPR consists of 3 cycles of standard CPR with each cycle consisting of 30 chest compressions with a pause for 2 ventilations at a compression:ventilation ratio of 30:2. CCC consists of a series of three cycles of continuous chest compressions without pauses for ventilation. In either group, each cycle will be followed by rhythm analysis until three cycles are completed or restoration of spontaneous circulation (ROSC), whichever occurs first.
Continuous Chest Compressions
n=12603 Participants
Continuous compression CPR Continuous chest compressions: Continuous chest compressions during the first 6 minutes of the resuscitation.
Number of Participants Who Survive From the Time of Cardiac Arrest to Hospital Discharge
1072 participants
1127 participants

SECONDARY outcome

Timeframe: Patients will be followed from the time of the cardiac arrest until death or hospital discharge, whichever occurs first.

Neurologic status at discharge will be assessed using the modified Rankin Score (MRS). A higher value indicates a worse outcome. 0-No symptoms at all; 1-No significant disability despite symptoms; able to carry out all usual duties and activities, 2-Slight disability; unable to carry out all previous activities, but able to look after own affairs without assistance, 3-Moderate disability; requiring some help, but able to walk without assistance; 4-Moderately severe disability; unable to walk without assistance and unable to attend to own bodily needs without assistance, 5-Severe disability; bedridden, incontinent and requiring constant nursing care and attention; 6-Dead

Outcome measures

Outcome measures
Measure
Standard CPR
n=10892 Participants
American Heart Association (AHA)recommended cardiopulmonary resuscitation (CPR) of 30 compressions with brief pause for 2 ventilations Standard CPR: 30:2 CPR consists of 3 cycles of standard CPR with each cycle consisting of 30 chest compressions with a pause for 2 ventilations at a compression:ventilation ratio of 30:2. CCC consists of a series of three cycles of continuous chest compressions without pauses for ventilation. In either group, each cycle will be followed by rhythm analysis until three cycles are completed or restoration of spontaneous circulation (ROSC), whichever occurs first.
Continuous Chest Compressions
n=12550 Participants
Continuous compression CPR Continuous chest compressions: Continuous chest compressions during the first 6 minutes of the resuscitation.
Percentage of Participants Scoring at or Below a 3 on the MRS Scale
7.7 percentage of participants
7.0 percentage of participants

Adverse Events

Standard CPR

Serious events: 0 serious events
Other events: 1197 other events
Deaths: 0 deaths

Continuous Chest Compressions

Serious events: 0 serious events
Other events: 1310 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Standard CPR
n=11045 participants at risk
American Heart Association (AHA)recommended cardiopulmonary resuscitation (CPR) of 30 compressions with brief pause for 2 ventilations Standard CPR: 30:2 CPR consists of 3 cycles of standard CPR with each cycle consisting of 30 chest compressions with a pause for 2 ventilations at a compression:ventilation ratio of 30:2. CCC consists of a series of three cycles of continuous chest compressions without pauses for ventilation. In either group, each cycle will be followed by rhythm analysis until three cycles are completed or restoration of spontaneous circulation (ROSC), whichever occurs first.
Continuous Chest Compressions
n=12642 participants at risk
Continuous compression CPR Continuous chest compressions: Continuous chest compressions during the first 6 minutes of the resuscitation.
Respiratory, thoracic and mediastinal disorders
Airway Bleed
6.9%
764/11045 • Adverse event data were collected from the time a participating agency arrived on scene and up to 24 hours after Emergency Department arrival
The following are commonly observed in patients who experience cardiac arrest or resuscitative efforts, and may or may not be attributable to specific resuscitation therapies. These were monitored and reported but not considered as adverse events of the study intervention. These include, but not limited to: pulmonary edema, airway bleeding, death, Clinical diagnoses of pneumonia, sepsis, cerebral bleeding, stroke, seizures, rearrest, serious rib fractures, and sternal fractures.
7.0%
881/12642 • Adverse event data were collected from the time a participating agency arrived on scene and up to 24 hours after Emergency Department arrival
The following are commonly observed in patients who experience cardiac arrest or resuscitative efforts, and may or may not be attributable to specific resuscitation therapies. These were monitored and reported but not considered as adverse events of the study intervention. These include, but not limited to: pulmonary edema, airway bleeding, death, Clinical diagnoses of pneumonia, sepsis, cerebral bleeding, stroke, seizures, rearrest, serious rib fractures, and sternal fractures.
Gastrointestinal disorders
Emesis
10.8%
1197/11045 • Adverse event data were collected from the time a participating agency arrived on scene and up to 24 hours after Emergency Department arrival
The following are commonly observed in patients who experience cardiac arrest or resuscitative efforts, and may or may not be attributable to specific resuscitation therapies. These were monitored and reported but not considered as adverse events of the study intervention. These include, but not limited to: pulmonary edema, airway bleeding, death, Clinical diagnoses of pneumonia, sepsis, cerebral bleeding, stroke, seizures, rearrest, serious rib fractures, and sternal fractures.
10.4%
1310/12642 • Adverse event data were collected from the time a participating agency arrived on scene and up to 24 hours after Emergency Department arrival
The following are commonly observed in patients who experience cardiac arrest or resuscitative efforts, and may or may not be attributable to specific resuscitation therapies. These were monitored and reported but not considered as adverse events of the study intervention. These include, but not limited to: pulmonary edema, airway bleeding, death, Clinical diagnoses of pneumonia, sepsis, cerebral bleeding, stroke, seizures, rearrest, serious rib fractures, and sternal fractures.
Respiratory, thoracic and mediastinal disorders
Pulmonary Edema
9.7%
1072/11045 • Adverse event data were collected from the time a participating agency arrived on scene and up to 24 hours after Emergency Department arrival
The following are commonly observed in patients who experience cardiac arrest or resuscitative efforts, and may or may not be attributable to specific resuscitation therapies. These were monitored and reported but not considered as adverse events of the study intervention. These include, but not limited to: pulmonary edema, airway bleeding, death, Clinical diagnoses of pneumonia, sepsis, cerebral bleeding, stroke, seizures, rearrest, serious rib fractures, and sternal fractures.
9.0%
1137/12642 • Adverse event data were collected from the time a participating agency arrived on scene and up to 24 hours after Emergency Department arrival
The following are commonly observed in patients who experience cardiac arrest or resuscitative efforts, and may or may not be attributable to specific resuscitation therapies. These were monitored and reported but not considered as adverse events of the study intervention. These include, but not limited to: pulmonary edema, airway bleeding, death, Clinical diagnoses of pneumonia, sepsis, cerebral bleeding, stroke, seizures, rearrest, serious rib fractures, and sternal fractures.

Additional Information

Dr. Susanne May

University of Washington, Resuscitation Outcomes Consortium

Phone: 206-685-1302

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place

Restriction type: LTE60